![](/img/cover-not-exists.png)
A Phase II intra-patient dose-escalation trial of weight-based darbepoetin alfa with or without granulocyte-colony stimulating factor in myelodysplastic syndromes
Jason Gotlib, Philip Lavori, Sylvia Quesada, Richard S. Stein, Shahin Shahnia, Peter L. GreenbergVolume:
84
Year:
2009
Language:
english
Pages:
6
DOI:
10.1002/ajh.21316
File:
PDF, 141 KB
english, 2009